| Financial Year |
March 31 2023 |
| Monetary Funds |
1,549,758,731.49 |
| Held-for-trading Financial Assets |
141,170,000.00 |
| Notes Receivable |
59,846,342.54 |
| Accounts Receivable |
1,003,778,528.90 |
| Advances to Suppliers |
15,088,134.10 |
| Other Receivables |
52,987,533.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
368,874,487.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
61,942,979.43 |
| Total Current Assets |
3,306,936,456.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
37,422,346.28 |
| Investment Properties |
1,856,682,516.59 |
| Fixed Assetes |
1,734,206,159.34 |
| Under-construction Projects |
4,849,317.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
569,994.27 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
275,202,755.95 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,130,459.81 |
| Deferred Income Tax Assets |
19,205,453.92 |
| Other Non-Current Assets |
10,003,544.11 |
| Sub-Total of Non-Current Assets |
4,018,674,159.80 |
| Total Assets |
7,325,610,616.66 |
| Short-Term Loans |
397,533,293.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
502,498,614.54 |
| Accounts Payable |
456,725,777.23 |
| Accounts Received In Advance |
411,157.53 |
| Employee Compensation Payable |
42,023,702.62 |
| Taxes Payable |
42,246,353.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
61,265,833.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
27,164,238.95 |
| Other Current Liabilities |
1,008,981.28 |
| Sub-Total of Current Liabilities |
1,539,179,281.01 |
| Long-term Loans |
433,245,499.46 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
165,556,284.67 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
691,805,352.94 |
| Total Liabilities |
2,230,984,633.95 |
| Paid-In Capital(Or Share Stock) |
1,531,323,685.00 |
| Capital Surplus |
1,243,285,096.60 |
| Surplus Reserve |
249,043,840.84 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,358,341,144.74 |
| Minority Stockholder's Interest |
56,732,927.14 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,037,893,055.57 |
| Owner's Equity（Stockholder's Equity） |
5,094,625,982.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,325,610,616.66 |
